These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 9042615
1. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Newman-Tancredi A, Audinot-Bouchez V, Gobert A, Millan MJ. Eur J Pharmacol; 1997 Jan 29; 319(2-3):379-83. PubMed ID: 9042615 [Abstract] [Full Text] [Related]
3. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL. J Pharmacol Exp Ther; 1998 Oct 29; 287(1):167-86. PubMed ID: 9765336 [Abstract] [Full Text] [Related]
9. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors. Roberts DJ, Lin H, Strange PG. Biochem Pharmacol; 2004 May 01; 67(9):1657-65. PubMed ID: 15081865 [Abstract] [Full Text] [Related]
10. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells. Kung MP, Stevenson DA, Zhuang ZP, Vessotskie JM, Chumpradit S, Sun XM, Kung HF. Life Sci; 1997 May 01; 60(2):91-100. PubMed ID: 9000114 [Abstract] [Full Text] [Related]
12. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P. Br J Pharmacol; 1998 Jul 01; 124(5):889-96. PubMed ID: 9692773 [Abstract] [Full Text] [Related]
14. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor. Gazi L, Schoeffter P, Nunn C, Croskery K, Hoyer D, Feuerbach D. Naunyn Schmiedebergs Arch Pharmacol; 2000 May 01; 361(5):555-64. PubMed ID: 10832611 [Abstract] [Full Text] [Related]
15. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding. Malmberg, Mikaels, Mohell N. J Pharmacol Exp Ther; 1998 Apr 01; 285(1):119-26. PubMed ID: 9536001 [Abstract] [Full Text] [Related]
16. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist. Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH. Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032 [Abstract] [Full Text] [Related]
17. Serotonergic agonists behave as partial agonists at the dopamine D2 receptor. Rinken A, Ferré S, Terasmaa A, Owman C, Fuxe K. Neuroreport; 1999 Feb 25; 10(3):493-5. PubMed ID: 10208577 [Abstract] [Full Text] [Related]
18. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole. Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. J Pharmacol Exp Ther; 2004 Jun 25; 309(3):903-20. PubMed ID: 14978194 [Abstract] [Full Text] [Related]
20. Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPγS assays. Zhen J, Antonio T, Ali S, Neve KA, Dutta AK, Reith ME. J Neurosci Methods; 2015 Jun 15; 248():7-15. PubMed ID: 25840364 [Abstract] [Full Text] [Related] Page: [Next] [New Search]